- Home
- ACRV vs MLSS Comparison
ACRV vs MLSS Comparison
Compare ACRV & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- MLSS
- Stock Information
- Founded
- ACRV 2018
- MLSS 1989
- Country
- ACRV United States
- MLSS United States
- Employees
- ACRV N/A
- MLSS N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- MLSS Industrial Specialties
- Sector
- ACRV Health Care
- MLSS Health Care
- Exchange
- ACRV Nasdaq
- MLSS Nasdaq
- Market Cap
- ACRV 47.8M
- MLSS 42.4M
- IPO Year
- ACRV 2022
- MLSS 1995
- Fundamental
- Price
- ACRV $2.01
- MLSS $0.55
- Analyst Decision
- ACRV Buy
- MLSS Buy
- Analyst Count
- ACRV 6
- MLSS 1
- Target Price
- ACRV $17.75
- MLSS $1.25
- AVG Volume (30 Days)
- ACRV 556.9K
- MLSS 152.3K
- Earning Date
- ACRV 11-12-2025
- MLSS 11-13-2025
- Dividend Yield
- ACRV N/A
- MLSS N/A
- EPS Growth
- ACRV N/A
- MLSS N/A
- EPS
- ACRV N/A
- MLSS N/A
- Revenue
- ACRV N/A
- MLSS $9,083,205.00
- Revenue This Year
- ACRV N/A
- MLSS $16.06
- Revenue Next Year
- ACRV $805.34
- MLSS $14.73
- P/E Ratio
- ACRV N/A
- MLSS N/A
- Revenue Growth
- ACRV N/A
- MLSS 7.84
- 52 Week Low
- ACRV $1.05
- MLSS $0.38
- 52 Week High
- ACRV $8.74
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- ACRV 69.57
- MLSS 58.45
- Support Level
- ACRV $1.82
- MLSS $0.40
- Resistance Level
- ACRV $2.00
- MLSS $0.46
- Average True Range (ATR)
- ACRV 0.12
- MLSS 0.02
- MACD
- ACRV 0.01
- MLSS 0.01
- Stochastic Oscillator
- ACRV 87.68
- MLSS 75.05
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.